BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 31631043)

  • 1. Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy.
    Montalban-Arques A; Scharl M
    EBioMedicine; 2019 Oct; 48():648-655. PubMed ID: 31631043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
    Liu Y; Lau HC; Cheng WY; Yu J
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
    Farhana L; Banerjee HN; Verma M; Majumdar APN
    Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
    Kim J; Lee HK
    Front Immunol; 2021; 12():807648. PubMed ID: 35069592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer.
    Azimi M; Keshavarz Shahbaz S; Mansourabadi AH; Mohamed Khosroshahi L; Pourkalhor S; Rezakhani M; Masoumi F
    Int Arch Allergy Immunol; 2022; 183(11):1147-1165. PubMed ID: 35988536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
    Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
    Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer.
    Koliarakis I; Messaritakis I; Nikolouzakis TK; Hamilos G; Souglakos J; Tsiaoussis J
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
    Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
    Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbe-based therapies for colorectal cancer: Advantages and limitations.
    Saeed M; Shoaib A; Kandimalla R; Javed S; Almatroudi A; Gupta R; Aqil F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):652-665. PubMed ID: 34020027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between intestinal microorganisms and T lymphocytes in colorectal cancer.
    Shuwen H; Xi Y; Quan Q; Yuefen P; Miao D; Qing Z
    Future Oncol; 2019 May; 15(14):1655-1666. PubMed ID: 31044617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer.
    Pös O; Styk J; Buglyó G; Zeman M; Lukyova L; Bernatova K; Hrckova Turnova E; Rendek T; Csók Á; Repiska V; Nagy B; Szemes T
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota and colorectal cancer: a new aspect of research.
    Koliarakis I; Psaroulaki A; Nikolouzakis TK; Kokkinakis M; Sgantzos MN; Goulielmos G; Androutsopoulos VP; Tsatsakis A; Tsiaoussis J
    J BUON; 2018; 23(5):1216-1234. PubMed ID: 30512251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and epigenetics in colorectal cancer: implications for carcinogenesis and therapeutic intervention.
    Pandey M; Bhattacharyya J
    Epigenomics; 2024 Mar; 16(6):403-418. PubMed ID: 38410915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota in colorectal cancer development and therapy.
    Wong CC; Yu J
    Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Wong SH; Yu J
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
    Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
    Front Immunol; 2021; 12():612826. PubMed ID: 33841394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.